Crinetics Pharmaceuticals, Inc. (DELISTED) (CRNX:DL)
84.95
0.00 (0.00%)
USD |
NASDAQ |
Sep 10, 16:00
Crinetics Pharmaceuticals Max Drawdown (5Y) : 58.40% for Aug. 31, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| August 31, 2026 | 58.40% |
| July 31, 2026 | 58.40% |
| June 30, 2026 | 58.40% |
| May 31, 2026 | 58.40% |
| April 30, 2026 | 58.40% |
| March 31, 2026 | 58.40% |
| February 28, 2026 | 60.73% |
| January 31, 2026 | 61.77% |
| December 31, 2025 | 63.86% |
| November 30, 2025 | 64.86% |
| October 31, 2025 | 66.44% |
| September 30, 2025 | 67.17% |
| August 31, 2025 | 67.17% |
| July 31, 2025 | 67.17% |
| June 30, 2025 | 67.17% |
| May 31, 2025 | 67.17% |
| April 30, 2025 | 67.17% |
| March 31, 2025 | 67.17% |
| February 28, 2025 | 68.70% |
| January 31, 2025 | 68.70% |
| December 31, 2024 | 68.70% |
| November 30, 2024 | 68.70% |
| October 31, 2024 | 68.70% |
| September 30, 2024 | 68.70% |
| August 31, 2024 | 68.70% |
| Date | Value |
|---|---|
| July 31, 2024 | 68.70% |
| June 30, 2024 | 68.70% |
| May 31, 2024 | 68.70% |
| April 30, 2024 | 68.70% |
| March 31, 2024 | 68.70% |
| February 29, 2024 | 68.70% |
| January 31, 2024 | 68.70% |
| December 31, 2023 | 68.70% |
| November 30, 2023 | 68.70% |
| October 31, 2023 | 68.70% |
| September 30, 2023 | 68.70% |
| August 31, 2023 | 68.70% |
| July 31, 2023 | 68.70% |
| June 30, 2023 | 68.70% |
| May 31, 2023 | 68.70% |
| April 30, 2023 | 68.70% |
| March 31, 2023 | 68.70% |
| February 28, 2023 | 68.70% |
| January 31, 2023 | 68.70% |
| December 31, 2022 | 68.70% |
| November 30, 2022 | 68.70% |
| October 31, 2022 | 68.70% |
| September 30, 2022 | 68.70% |
| August 31, 2022 | 68.70% |
| July 31, 2022 | 68.70% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Vertex Pharmaceuticals, Inc. | 41.60% |
| Johnson & Johnson | 18.44% |
| Eli Lilly & Co. | 34.47% |
| Bristol Myers Squibb Co. | 47.67% |
| Corcept Therapeutics, Inc. | 71.85% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | 24.80 |
| Beta (5Y) | 0.0785 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 82.64% |
| Historical Sharpe Ratio (5Y) | 0.3087 |
| Historical Sortino (5Y) | 0.9299 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 20.37% |